Oncology
CAR-T close up

CAR-T has a geography problem

The gap between what CAR-T can do and who can actually get it is the defining challenge of this field right now.

R&D
Female scientist in the lab

Clinical research demands agile CROs

An emerging consensus across sponsors, investigators, and regulators is that agility must become a defining attribute of CRO performance.

Sales & Marketing
12 questions with Dermot Kenny
Sponsored

12 Questions with Dermot Kenny

Dermot Kenny, who leads STEM and Research Partnership at Inizio Advisory, shares his journey from bench scientist to CEO in a new 12 Questions With.

Sales & Marketing

Sales & Marketing
12 Questions with Shauna Lord
Sponsored

12 Questions with Shauna Lord

Shauna Lord recently joined GSK as Business Unit Head Specialty (UK Commercial) to lead the Specialty business in the UK.

Digital

Market Access

Editor's Picks

  1. Lilly launches its LillyDirect sales channel in the UK
  2. HHS details plan to regain the US's edge in clinical trials
  3. Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance
  4. EFPIA report adds to pressures on EU drug pricing policy
  5. Obesity is rising fastest in young adults in England

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
CAR-T close up

CAR-T has a geography problem

The gap between what CAR-T can do and who can actually get it is the defining challenge of this field right now.

more

Patients

Patients
PSP services
Sponsored

Designing global PSPs for the real world

How integrating strategic design with implementation expertise can help create more scalable, locally relevant, and effective global PSPs.

more

R&D

more